M&T Bank
IPXL

M&T Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

M&T Bank’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,218
Closed -$239K – 2133
2015
Q2 		$239K Buy
+5,218
New +$248K ﹤0.01% 1642

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

M&T Bank's IPXL Position: Q3 2015 in Review

M&T Bank sold out of Impax Laboratories, Inc. (IPXL) in Q3 2015, closing a stake of 5,218 shares — an estimated $239K sold.

M&T Bank first reported a position in IPXL in Q2 2015 and held it in 1 quarter. The position peaked at $239K in Q2 2015. 195 funds tracked by Wall St. Rank hold IPXL as of Q3 2015.

  • M&T Bank reported no remaining Impax Laboratories, Inc. position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 5,218 Impax Laboratories, Inc. shares in Q3 2015, an estimated $239K.
  • M&T Bank first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 1 quarter.
  • M&T Bank's Impax Laboratories, Inc. position peaked at $239K in Q2 2015.
  • 195 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.